Using orally administered zinc to patients already diagnosed with the pre-cancerous
condition, Barrett's Esophagus, this study is asking two questions:
1. can this zinc administration cause molecular-level changes in the Barrett's tissue?
2. are the changes measured indicative of chemopreventive action by zinc regarding cancer
progression?